反応式
[OH:1][CH:2]1[CH2:7][CH2:6][CH:5]([NH:8][C:9]([C:11]2[C:15]([N+]([O-])=O)=[CH:14][NH:13][N:12]=2)=[O:10])[CH2:4][CH2:3]1.[O:19]1[CH:24]=[CH:23][CH2:22][CH2:21][CH2:20]1.O.C1(C)C=CC(S(O)(=O)=O)=CC=1.[O:37]1[CH:42]=[CH:41][CH:40]=[CH:39][CH2:38]1>C(Cl)Cl.C(Cl)(Cl)Cl.C1COCC1>[O:19]1[CH2:20][CH2:21][CH2:22][CH2:23][CH:24]1[O:1][CH:2]1[CH2:3][CH2:4][CH:5]([NH:8][C:9]([C:11]2[CH:15]=[CH:14][N:13]([CH:38]3[CH2:39][CH2:40][CH2:41][CH2:42][O:37]3)[N:12]=2)=[O:10])[CH2:6][CH2:7]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
A solution of 4-nitro-1H-pyrazole-3-carboxylic acid 4-hydroxy-cyclohexylamide (1.95 g; 7.67 mmol) in a mix of THF (50 ml) and chloroform (100 ml), was treated with 3,4-dihydro-2H-pyran (1.54 ml, 15.34 mmol) and p-toluenesulphonic acid monohydrate (100 mg). The reaction mixture was stirred at room temperature overnight, and then excess pyran (0.9 ml) was added in total to bring reaction to completion. The reaction mixture was diluted with CH2Cl2 and washed successively with saturated aqueous sodium bicarbonate, water and brine. The resulting solution was reduced in vacuo and subject to Biotage column chromatography, eluting with hexane (2 column lengths) followed by 30% ethyl acetate:hexane (10 column lengths), 70% ethyl acetate:hexane (10 column lengths) to give 1.25 g of 4-nitro-1-(tetrahydro-pyran-2-yl-1H-pyrazole-3-carboxylic acid [4-(tetrahydro-pyran-2-yloxy)-cyclohexyl]-amide. (LC/MS: Rt 2.97, [M+H]+ 423).
後処理
- customreaction to completion
- washwashed successively with saturated aqueous sodium bicarbonate, water and brine
- washeluting with hexane (2 column lengths)
出典と根拠
- ORDレコード
- ord-e8361d8943ed48b8b3d4e8688c346a2f
- 出典データセット
- uspto-grants-2011_12
- 特許番号
- US08080666B2
関連ノート
読み込み中…